FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE for Pulmonary fibrosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 40 adverse event reports in the FDA FAERS database where FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE was used for Pulmonary fibrosis.
Most Reported Side Effects for FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 3,539 | 13.7% | 151 | 928 |
| Wrong technique in device usage process | 2,673 | 10.3% | 1 | 75 |
| Drug ineffective | 2,522 | 9.7% | 53 | 404 |
| Product complaint | 2,417 | 9.3% | 3 | 75 |
| Product dose omission issue | 2,235 | 8.6% | 18 | 209 |
| Death | 1,660 | 6.4% | 1,634 | 147 |
| Cough | 1,520 | 5.9% | 16 | 192 |
| Asthma | 1,275 | 4.9% | 77 | 971 |
| Hospitalisation | 1,259 | 4.9% | 40 | 1,257 |
| Chronic obstructive pulmonary disease | 1,145 | 4.4% | 180 | 797 |
| Pneumonia | 1,064 | 4.1% | 117 | 707 |
| Dysphonia | 943 | 3.6% | 0 | 46 |
| Product use in unapproved indication | 735 | 2.8% | 83 | 168 |
| Condition aggravated | 718 | 2.8% | 160 | 262 |
| Product dispensing error | 692 | 2.7% | 2 | 10 |
Other Indications for FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE
Product used for unknown indication (13,652)
Chronic obstructive pulmonary disease (8,730)
Asthma (2,468)
Emphysema (377)
Dyspnoea (290)
Cough (96)
Lung disorder (85)
Bronchitis (81)
Asthma-chronic obstructive pulmonary disease overlap syndrome (68)
Lung neoplasm malignant (38)
Other Drugs Used for Pulmonary fibrosis
PIRFENIDONE (3,063)
NINTEDANIB (1,539)
RITUXIMAB (201)
TREPROSTINIL (171)
AMBRISENTAN (168)
FLUTICASONE\SALMETEROL (148)
UNSPECIFIED INGREDIENT (118)
MYCOPHENOLATE MOFETIL (106)
ALBUTEROL (62)
PREDNISONE (54)